Title | Draft: Increased Reimbursement of Medications for the Treatment of Opioid Use Disorder |
Document ID | 7294 |
Effective Date | 12/8/2022 |
View document text Posted On 12/9/2022 Document on Town Hall |
Proposed Change | Register Date | Status |
---|---|---|
The purpose of this memo is to notify Medicaid enrolled pharmacy providers that DMAS fee-for-service (FFS) and the Medicaid Managed Care Organizations will provide up to five professional dispense fees per month (defined as a rolling 30 day period) for buprenorphine-based opioid use disorder (OUD) p.... | 11/7/2022 | Forum ended on 12/7/2022 with 0 Comments. |